Affordable AI-Powered cervical cancer screening and treatment guide for LMICs
Official title: A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs
Funded at International Agency for Res on Cancer · NIH-11535280 · Data updated 2026-11-12
A new AI-based system helps screen, triage, and choose treatments for cervical pre-cancer and cancer in low- and middle-income countries.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | International Agency for Res on Cancer NIH-funded |
| Lab location | 1 site (Lyon, France) |
| Project start | August 15, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $95,633 |
| NIH project number | 3R37CA275824-04S1 |
| Project ID | NIH-11535280 on NIH RePORTER |
Who could benefit from this research
✓Could help
Women who are screen-eligible for cervical cancer prevention, including those HPV-positive or at risk of pre-cancer/cancer, in LMICs and the USA.
✕Less likely to help
Patients who have no cervical cancer risk or who are not candidates for the proposed AI-guided procedures may not benefit.
What this research studies
This project aims to develop an AI system that analyzes urine tests for high-risk HPV and cervical images to identify high-grade lesions. It will work in Zimbabwe and the United States to support screening, triage, and treatment decisions. The approach uses infrared signals from urine and cervical images captured with a dedicated camera to guide the best therapy option.
Why it matters
Potential benefit: If successful, it could streamline screening and treatment decisions, reducing missed cases and enabling timely care for women.
How similar studies have gone: Preliminary AI approaches have shown promise in image-based cervical cancer screening but may require validation across settings and populations.
Where this research is happening
-
International Agency for Res on Cancer
Lyon, France Active
Researchers
- Principal investigator: Basu, Partha — International Agency for Res on Cancer
- Study coordinator: Basu, Partha
Related research
Other NIH-funded projects on the same topics.
-
Community and digital tools to reduce HPV and cervical cancer burden
A nurse or health team will test a community-based, digital strategy to help girls and young women, especially in rural areas, get HPV vaccination and cervical cancer prevention services.
-
Community and digital tools to reduce HPV and cervical cancer in women with HIV
A community- and digital-technology program aims to help girls and young women, including those with HIV, get more HPV vaccination and cervical cancer prevention services.
-
mSaada: a mobile tool to boost cervical cancer screening in western Kenya
A mobile app helps community health volunteers manage cervical cancer screening tasks and follow-up for women in low-resource areas.
-
Globally useful predictor for cervical cancer treatment response
This project aims to develop a simple predictive signature to personalize treatment for locally advanced cervical cancer using easy tests and imaging.
-
HPV self-collection in HIV care to screen for cervical cancer in Ethiopia
A patient-centered program tests a simple HPV self-collection approach within HIV clinics in Ethiopia to help detect cervical cancer earlier.
-
Hybrid approach to boost cervical cancer screening in Uganda
A tested, community-driven program helps Ugandan women encourage their peers to get free VIA cervical cancer screening.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.